# Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent

Study · id `cardio:ct-nct01336101` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01336101](<https://clinicaltrials.gov/study/NCT01336101>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01336101

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01336101. Allocation not applicable; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01336101, source copy `cardio:ctgov-nct01336101-2014-04-24`, retrieved 2026-10-31)
- Start date: 2011-04 (registry gives no type) (ClinicalTrials.gov record NCT01336101, source copy `cardio:ctgov-nct01336101-2014-04-24`, retrieved 2026-10-31)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01336101, source copy `cardio:ctgov-nct01336101-2014-04-24`, retrieved 2026-10-31)
- Completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01336101, source copy `cardio:ctgov-nct01336101-2014-04-24`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT01336101, source copy `cardio:ctgov-nct01336101-2014-04-24`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01336101-2014-04-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent
- Acronym: SUMMIT
- Condition: Peripheral Arterial Diseases
- Condition: Superficial Femoral Artery Stenosis
- Intervention (Device): EPIC™ Self-Expanding Nitinol Vascular Stent
- Lead sponsor: Provascular GmbH
- Lead sponsor class: OTHER
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: ea031f1d2e0561060ce1a9f63a345d81222fa70d986e6ee0b99a830b5964da43
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
